- Home
- PCVX vs FHN Comparison
PCVX vs FHN Comparison
Compare PCVX & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- FHN
- Stock Information
- Founded
- PCVX 2013
- FHN 1864
- Country
- PCVX United States
- FHN United States
- Employees
- PCVX N/A
- FHN N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- FHN Major Banks
- Sector
- PCVX Health Care
- FHN Finance
- Exchange
- PCVX Nasdaq
- FHN Nasdaq
- Market Cap
- PCVX 4.0B
- FHN 11.0B
- IPO Year
- PCVX 2020
- FHN N/A
- Fundamental
- Price
- PCVX $32.19
- FHN $22.57
- Analyst Decision
- PCVX Strong Buy
- FHN Buy
- Analyst Count
- PCVX 8
- FHN 17
- Target Price
- PCVX $114.17
- FHN $23.32
- AVG Volume (30 Days)
- PCVX 1.5M
- FHN 11.2M
- Earning Date
- PCVX 11-04-2025
- FHN 10-15-2025
- Dividend Yield
- PCVX N/A
- FHN 2.69%
- EPS Growth
- PCVX N/A
- FHN 28.04
- EPS
- PCVX N/A
- FHN 1.55
- Revenue
- PCVX N/A
- FHN $3,083,000,000.00
- Revenue This Year
- PCVX N/A
- FHN $10.95
- Revenue Next Year
- PCVX N/A
- FHN $3.68
- P/E Ratio
- PCVX N/A
- FHN $14.39
- Revenue Growth
- PCVX N/A
- FHN 4.62
- 52 Week Low
- PCVX $27.66
- FHN $14.83
- 52 Week High
- PCVX $121.06
- FHN $23.08
- Technical
- Relative Strength Index (RSI)
- PCVX 50.57
- FHN 54.27
- Support Level
- PCVX $30.81
- FHN $21.94
- Resistance Level
- PCVX $33.32
- FHN $23.08
- Average True Range (ATR)
- PCVX 1.25
- FHN 0.45
- MACD
- PCVX 0.08
- FHN -0.04
- Stochastic Oscillator
- PCVX 55.67
- FHN 55.25
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.